share_log

共同药业:监事会关于公司2023年限制性股票激励计划预留授予激励对象名单的核查意见及公示情况说明

Kyodo Pharmaceutical: Explanation of the supervisory board's inspection opinions and disclosure on the list of incentive recipients reserved for the company's 2023 restricted stock incentive plan

SZSI ·  Mar 19
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more